-
1
-
-
0028968949
-
Tyrosine kinase inhibition: An approach to drug development
-
Levitzki A, Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science. 1995;267: 1782-1788.
-
(1995)
Science
, vol.267
, pp. 1782-1788
-
-
Levitzki, A.1
Gazit, A.2
-
2
-
-
0000358194
-
Case of disease of the spleen, in which death took place in consequence of the presence of purulent matter in the blood
-
Craigie D. Case of disease of the spleen, in which death took place in consequence of the presence of purulent matter in the blood. Edinburgh Med Surg J. 1845;64:400-413.
-
(1845)
Edinburgh Med Surg J
, vol.64
, pp. 400-413
-
-
Craigie, D.1
-
3
-
-
0000358195
-
Case of hypertrophy of the spleen and liver, in which death took place from suppuration of the blood
-
Bennett JH. Case of hypertrophy of the spleen and liver, in which death took place from suppuration of the blood. Edinburgh Med Sug J. 1845;64:413-423.
-
(1845)
Edinburgh Med Sug J
, vol.64
, pp. 413-423
-
-
Bennett, J.H.1
-
4
-
-
0000690351
-
Weisses blut
-
Virchow R. Weisses blut. Froiep Notizen. 1845;36: 151-156.
-
(1845)
Froiep Notizen
, vol.36
, pp. 151-156
-
-
Virchow, R.1
-
5
-
-
72849159485
-
Chromosome studies on normal and leukemic human leukocytes
-
Nowell PC, Hungerford DA. Chromosome studies on normal and leukemic human leukocytes. J Natl Cancer Inst. 1960;25:85-109.
-
(1960)
J Natl Cancer Inst
, vol.25
, pp. 85-109
-
-
Nowell, P.C.1
Hungerford, D.A.2
-
6
-
-
0015694748
-
A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and giemsa staining
-
Rowley JD. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and giemsa staining. Nature. 1973;243:290-293.
-
(1973)
Nature
, vol.243
, pp. 290-293
-
-
Rowley, J.D.1
-
7
-
-
0014837635
-
Lymphosarcoma: Virus-induced thymic-independent disease in mice
-
Abelson HT, Rabstein LS. Lymphosarcoma: virus-induced thymic-independent disease in mice. Cancer Res. 1970;30:2213-2222.
-
(1970)
Cancer Res
, vol.30
, pp. 2213-2222
-
-
Abelson, H.T.1
Rabstein, L.S.2
-
8
-
-
0006301124
-
In vitro transformation of lymphoid cells by Abelson murine leukemia virus
-
Rosenberg N, Baltimore D, Scher CD. In vitro transformation of lymphoid cells by Abelson murine leukemia virus. Proc Natl Acd Sci USA. 1975;72:1932-1936.
-
(1975)
Proc Natl Acd Sci USA
, vol.72
, pp. 1932-1936
-
-
Rosenberg, N.1
Baltimore, D.2
Scher, C.D.3
-
9
-
-
0021802841
-
Fused transcript of abl and bcr genes in chronic myelogenous leukemia
-
Shtivelman E, Lifshitz B, Gale RP, et al. Fused transcript of abl and bcr genes in chronic myelogenous leukemia. Nature. 1985;315:550-554.
-
(1985)
Nature
, vol.315
, pp. 550-554
-
-
Shtivelman, E.1
Lifshitz, B.2
Gale, R.P.3
-
10
-
-
0023133732
-
Unique forms of the ABL tyrosine kinase distinguish Ph-1 positive ALL
-
Clark SS, McLaughlin J, Crist WM, et al. Unique forms of the ABL tyrosine kinase distinguish Ph-1 positive ALL. Science. 1987;235:85-88.
-
(1987)
Science
, vol.235
, pp. 85-88
-
-
Clark, S.S.1
McLaughlin, J.2
Crist, W.M.3
-
11
-
-
0023903502
-
Expression of a distinctive BCR-ABL oncogene in Ph-1 positive acute lymphocytic leukemia (ALL)
-
Clark SS, McLaughlin J, Timmons M, et al. Expression of a distinctive BCR-ABL oncogene in Ph-1 positive acute lymphocytic leukemia (ALL). Science. 1988;239:775-777.
-
(1988)
Science
, vol.239
, pp. 775-777
-
-
Clark, S.S.1
McLaughlin, J.2
Timmons, M.3
-
13
-
-
0030031766
-
Inhibition of the Abl protein-tyrosine kinase inhibitor in vitro and in vivo by a 2-phenylaminopyrimidine derivative
-
Buchdunger E, Zimmermann J, Mett H, et al. Inhibition of the Abl protein-tyrosine kinase inhibitor in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res. 1996;56:100-104.
-
(1996)
Cancer Res
, vol.56
, pp. 100-104
-
-
Buchdunger, E.1
Zimmermann, J.2
Mett, H.3
-
14
-
-
0035810147
-
Efficacy and safety of a specific inhibitior of the BCR-ABL tyrosine kinase in chronic myeloid Leukemia
-
Druker BJ, Talpaz M, Resta DJ, et al. Efficacy and safety of a specific inhibitior of the BCR-ABL tyrosine kinase in chronic myeloid Leukemia. N Engl J Med. 2001;344:1031-1037.
-
(2001)
N Engl J Med
, vol.344
, pp. 1031-1037
-
-
Druker, B.J.1
Talpaz, M.2
Resta, D.J.3
-
15
-
-
0035810142
-
Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeroid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome
-
Druker B J, Sawyers C L, Kantarjian H, et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeroid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med. 2001; 344:1038-1042.
-
(2001)
N Engl J Med
, vol.344
, pp. 1038-1042
-
-
Druker, B.J.1
Sawyers, C.L.2
Kantarjian, H.3
-
16
-
-
0026775925
-
Effects of human stem-cell factor (c-Kit ligand) on proliferation of myeloid leukemia cells: Heterogeneity in response and synergy with other hematopoietic growth factors
-
Pietsch T, Kyas U, Steffens U, et al. Effects of human stem-cell factor (c-Kit ligand) on proliferation of myeloid leukemia cells: heterogeneity in response and synergy with other hematopoietic growth factors. Blood. 1992;80:1199-1206.
-
(1992)
Blood
, vol.80
, pp. 1199-1206
-
-
Pietsch, T.1
Kyas, U.2
Steffens, U.3
-
17
-
-
0028019224
-
Expression of stem-cell factor and c-kit in human neuroblastoma
-
The Children's Cancer Group
-
Cohen PS, Chan JP, Lipkunskaya M, et al. Expression of stem-cell factor and c-kit in human neuroblastoma. The Children's Cancer Group. Blood. 1994;84:3465-3472.
-
(1994)
Blood
, vol.84
, pp. 3465-3472
-
-
Cohen, P.S.1
Chan, J.P.2
Lipkunskaya, M.3
-
18
-
-
0029015913
-
Coexpression of the c-kit and stem-cell factor genes in breast carcinoma
-
Hines SJ, Organ C, Kornstein MJ, et al. Coexpression of the c-kit and stem-cell factor genes in breast carcinoma. Cell Growth Differ. 1995;6:769-779.
-
(1995)
Cell Growth Differ
, vol.6
, pp. 769-779
-
-
Hines, S.J.1
Organ, C.2
Kornstein, M.J.3
-
19
-
-
0027364148
-
Expression of c-kit and Kit ligand in human colon carcinoma cells
-
Toyota M, Hinoda Y, Takaoka A, et al. Expression of c-kit and Kit ligand in human colon carcinoma cells. Tumor Biol. 1993;14:295-302.
-
(1993)
Tumor Biol
, vol.14
, pp. 295-302
-
-
Toyota, M.1
Hinoda, Y.2
Takaoka, A.3
-
20
-
-
0028278087
-
Coexpression of the c-kit receptor and stem cell factor in gynecological tumors
-
Inoue M, Kyo S, Fujita M, et al. Coexpression of the c-kit receptor and stem cell factor in gynecological tumors. Cancer Res. 1994;54:3049-3053.
-
(1994)
Cancer Res
, vol.54
, pp. 3049-3053
-
-
Inoue, M.1
Kyo, S.2
Fujita, M.3
-
21
-
-
0026318821
-
Coexpression of the stem cell factor and the c-kit genes in small cell lung cancer
-
Hibi K, Takahashi T, Sekido Y, et al. Coexpression of the stem cell factor and the c-kit genes in small cell lung cancer. Oncogene. 1991;6:2291-2296.
-
(1991)
Oncogene
, vol.6
, pp. 2291-2296
-
-
Hibi, K.1
Takahashi, T.2
Sekido, Y.3
-
22
-
-
0028856070
-
Identification of a point mutation in the catalytic domain of the proto-oncogene c-kit in peripheral blood mononuclear cells of patients with systemic mastocytosis with an associated hematologic disorder
-
Nagata H, Worobee AS, Oh CK, et al. Identification of a point mutation in the catalytic domain of the proto-oncogene c-kit in peripheral blood mononuclear cells of patients with systemic mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA. 1995;92:10560-10564.
-
(1995)
Proc Natl Acad Sci USA
, vol.92
, pp. 10560-10564
-
-
Nagata, H.1
Worobee, A.S.2
Oh, C.K.3
-
23
-
-
15644363454
-
Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors
-
Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998;279:577-580.
-
(1998)
Science
, vol.279
, pp. 577-580
-
-
Hirota, S.1
Isozaki, K.2
Moriyama, Y.3
-
24
-
-
0035899418
-
STI571 inactivation of the gastro-intestinal stromal tumor c-KIT oncoprotein: Biological and clinical implications
-
Tuveson DA, Willis NA, Jacks T, et al. STI571 inactivation of the gastro-intestinal stromal tumor c-KIT oncoprotein: biological and clinical implications. Oncogene. 2001;20:5054-5058.
-
(2001)
Oncogene
, vol.20
, pp. 5054-5058
-
-
Tuveson, D.A.1
Willis, N.A.2
Jacks, T.3
-
25
-
-
0035810148
-
Effect of the tyrosine kinase inhibitor STI571 in a patient with metastatic gastrointesitnal stromal tumor
-
Joensuu H, Roberts PJ, Sarlomo-Rikala M, et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with metastatic gastrointesitnal stromal tumor. N Engl J Med. 2001;344:1052-1056.
-
(2001)
N Engl J Med
, vol.344
, pp. 1052-1056
-
-
Joensuu, H.1
Roberts, P.J.2
Sarlomo-Rikala, M.3
-
26
-
-
0037103424
-
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
-
Demeteri GD, von Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. New Engl J Med. 2002;347:472-480.
-
(2002)
New Engl J Med
, vol.347
, pp. 472-480
-
-
Demeteri, G.D.1
Von Mehren, M.2
Blanke, C.D.3
-
27
-
-
0011672458
-
ATP-site-directed competitive and irreversible inhibitors of protein kinases
-
Garcia-Echeverria C, Traxler P, Evans DB. ATP-site-directed competitive and irreversible inhibitors of protein kinases. Med Res Rev. 2000;20:28-57.
-
(2000)
Med Res Rev
, vol.20
, pp. 28-57
-
-
Garcia-Echeverria, C.1
Traxler, P.2
Evans, D.B.3
-
28
-
-
0035800507
-
Clinical resistance to STI-571 cancer therapy caused by bcr-abl gene mutation or amplification
-
Gorre ME, Mohammed M, Ellwood K, et al. Clinical resistance to STI-571 cancer therapy caused by bcr-abl gene mutation or amplification. Science. 2001;293:876-880.
-
(2001)
Science
, vol.293
, pp. 876-880
-
-
Gorre, M.E.1
Mohammed, M.2
Ellwood, K.3
|